Search results
Michael Lin Associate Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology
Michael Lin. Associate Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology. Our lab applies biochemical and engineering principles to the development of protein-based tools for imaging and control of biochemical processes.
Michael Z. Lin (born 1973 in Taipei, Taiwan) is a Taiwanese-American biochemist and bioengineer. He is an Associate Professor of Neurobiology and Bioengineering at Stanford University. He is best known for his work on engineering optically and chemically controllable proteins.
Michael Z. Lin, MD PhD. Laboratory of Intelligent Molecular Design. Because some things are better not left to chance. Departments of Neurobiology and Bioengineering at Stanford University. News.
View Michael Lin’s profile on LinkedIn, a professional community of 1 billion members. Experience: Stanford University School of Medicine · Location: Stanford · 391 connections on LinkedIn.
- Stanford University School of Medicine
Michael LIN, Professor (Assistant) | Cited by 17,486 | of Stanford University, CA (SU) | Read 114 publications | Contact Michael LIN
Michael Z. Lin, MD PhD. Principal Investigator. Michael Z. Lin received an A.B. summa cum laude in Biochemistry from Harvard, an M.D. from UCLA, and a Ph.D. from Harvard Medical School.
Bioluminescence helps Wu Tsai Neuro affiliate Michael Lin and team develop cancer drugs for brain.
Michael Lin. Associate Professor of Neurobiology, of Bioengineering and, by courtesy, of Chemical and Systems Biology. NIH Biosketch available Online. Curriculum Vitae available Online. CONTACT INFORMATION. • Administrative Contact. Alissa Ceja - Administrative Assistant. Email alceja@stanford.edu. Tel (650) 498-1780. Bio. BIO.
Research interests: Protein engineering for imaging and controlling signaling in living neurons, including drug-controllable tags for labeling and control of newly synthesized proteins of interest, new green and red fluorescent proteins for in vivo imaging and biosensing, and improved channelrhodopsins for controlling neuronal excitability.
